- Home
- CPBI vs ANVS Comparison
CPBI vs ANVS Comparison
Compare CPBI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- ANVS
- Stock Information
- Founded
- CPBI 2023
- ANVS 2008
- Country
- CPBI United States
- ANVS United States
- Employees
- CPBI N/A
- ANVS N/A
- Industry
- CPBI
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- ANVS Health Care
- Exchange
- CPBI Nasdaq
- ANVS Nasdaq
- Market Cap
- CPBI 56.9M
- ANVS 54.6M
- IPO Year
- CPBI N/A
- ANVS 2020
- Fundamental
- Price
- CPBI $14.88
- ANVS $2.34
- Analyst Decision
- CPBI
- ANVS Strong Buy
- Analyst Count
- CPBI 0
- ANVS 5
- Target Price
- CPBI N/A
- ANVS $30.25
- AVG Volume (30 Days)
- CPBI 4.5K
- ANVS 612.2K
- Earning Date
- CPBI 01-01-0001
- ANVS 08-14-2025
- Dividend Yield
- CPBI N/A
- ANVS N/A
- EPS Growth
- CPBI N/A
- ANVS N/A
- EPS
- CPBI 0.96
- ANVS N/A
- Revenue
- CPBI $18,899,000.00
- ANVS N/A
- Revenue This Year
- CPBI N/A
- ANVS N/A
- Revenue Next Year
- CPBI N/A
- ANVS N/A
- P/E Ratio
- CPBI $15.79
- ANVS N/A
- Revenue Growth
- CPBI 9.64
- ANVS N/A
- 52 Week Low
- CPBI $10.09
- ANVS $1.11
- 52 Week High
- CPBI $15.50
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- CPBI 46.71
- ANVS 47.84
- Support Level
- CPBI $14.88
- ANVS $2.05
- Resistance Level
- CPBI $14.99
- ANVS $2.37
- Average True Range (ATR)
- CPBI 0.15
- ANVS 0.26
- MACD
- CPBI -0.02
- ANVS -0.09
- Stochastic Oscillator
- CPBI 8.57
- ANVS 25.66
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.